MTOR and head and neck squamous cell carcinoma: Several studies have indicated that metformin treatment alone can decrease cancer proliferation using HNSCC cell lines, although each study describes a different mechanism of action, including AMPK-independent downregulation of the mTOR pathway or global inhibition of protein translation [27,28].